Specify a stock or a cryptocurrency in the search bar to get a summary
ANI Pharmaceuticals Inc
ANIPANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations, including extended release and combination products. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota. Address: 210 Main Street West, Baudette, MN, United States, 56623
Analytics
WallStreet Target Price
71.67 USDP/E ratio
96.0185Dividend Yield
4.44 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ANIP
Dividend Analytics ANIP
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ANIP
Stock Valuation ANIP
Financials ANIP
Results | 2019 | Dynamics |